IL6 and inflammatory bowel disease: B. acidifaciens may contribute to lower levels of IL-6 and TNF-α [40], promotion of IgA production [41], improvement of intestinal immune function, protection against intestinal pathogens, and reduction of the incidence of inflammatory bowel disease [42].